vs

Side-by-side financial comparison of ANTERO RESOURCES Corp (AR) and CABOT CORP (CBT). Click either name above to swap in a different company.

ANTERO RESOURCES Corp is the larger business by last-quarter revenue ($1.4B vs $849.0M, roughly 1.6× CABOT CORP). On growth, CABOT CORP posted the faster year-over-year revenue change (-11.1% vs -30.5%). Over the past eight quarters, ANTERO RESOURCES Corp's revenue compounded faster (17.6% CAGR vs -8.7%).

Antero Resources Corporation is an American company engaged in hydrocarbon exploration. It is organized in Delaware and headquartered in Denver, Colorado. The company's reserves are entirely in the Appalachian Basin and are extracted using hydraulic fracturing.

Cabot Corporation is an American specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company operates in over 20 countries with 36 manufacturing plants, eight research and development facilities, and 28 sales offices.

AR vs CBT — Head-to-Head

Bigger by revenue
AR
AR
1.6× larger
AR
$1.4B
$849.0M
CBT
Growing faster (revenue YoY)
CBT
CBT
+19.4% gap
CBT
-11.1%
-30.5%
AR
Faster 2-yr revenue CAGR
AR
AR
Annualised
AR
17.6%
-8.7%
CBT

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
AR
AR
CBT
CBT
Revenue
$1.4B
$849.0M
Net Profit
$73.0M
Gross Margin
24.9%
Operating Margin
20.1%
15.2%
Net Margin
8.6%
Revenue YoY
-30.5%
-11.1%
Net Profit YoY
-21.5%
EPS (diluted)
$0.66
$1.37

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AR
AR
CBT
CBT
Q1 26
$1.4B
Q4 25
$1.4B
$849.0M
Q3 25
$1.2B
$899.0M
Q2 25
$1.3B
$923.0M
Q1 25
$1.4B
$936.0M
Q4 24
$1.2B
$955.0M
Q3 24
$1.1B
$1.0B
Q2 24
$978.7M
$1.0B
Net Profit
AR
AR
CBT
CBT
Q1 26
Q4 25
$202.9M
$73.0M
Q3 25
$85.6M
$43.0M
Q2 25
$166.6M
$101.0M
Q1 25
$219.5M
$94.0M
Q4 24
$158.8M
$93.0M
Q3 24
$-25.2M
$137.0M
Q2 24
$-74.6M
$109.0M
Gross Margin
AR
AR
CBT
CBT
Q1 26
Q4 25
24.9%
Q3 25
24.5%
Q2 25
26.4%
Q1 25
25.7%
Q4 24
24.6%
Q3 24
24.0%
Q2 24
25.2%
Operating Margin
AR
AR
CBT
CBT
Q1 26
20.1%
Q4 25
20.5%
15.2%
Q3 25
9.7%
15.2%
Q2 25
15.8%
18.1%
Q1 25
20.1%
17.3%
Q4 24
4.9%
16.2%
Q3 24
-2.4%
15.0%
Q2 24
-8.2%
16.9%
Net Margin
AR
AR
CBT
CBT
Q1 26
Q4 25
14.4%
8.6%
Q3 25
7.1%
4.8%
Q2 25
12.8%
10.9%
Q1 25
16.2%
10.0%
Q4 24
13.6%
9.7%
Q3 24
-2.4%
13.7%
Q2 24
-7.6%
10.7%
EPS (diluted)
AR
AR
CBT
CBT
Q1 26
$0.66
Q4 25
$0.63
$1.37
Q3 25
$0.24
$0.80
Q2 25
$0.50
$1.86
Q1 25
$0.66
$1.69
Q4 24
$0.48
$1.67
Q3 24
$-0.11
$2.41
Q2 24
$-0.26
$1.94

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AR
AR
CBT
CBT
Cash + ST InvestmentsLiquidity on hand
$230.0M
Total DebtLower is stronger
$1.4B
Stockholders' EquityBook value
$7.6B
$1.6B
Total Assets
$13.2B
$3.8B
Debt / EquityLower = less leverage
0.19×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AR
AR
CBT
CBT
Q1 26
Q4 25
$230.0M
Q3 25
$258.0M
Q2 25
$239.0M
Q1 25
$213.0M
Q4 24
$183.0M
Q3 24
$223.0M
Q2 24
$197.0M
Total Debt
AR
AR
CBT
CBT
Q1 26
$1.4B
Q4 25
Q3 25
$1.1B
Q2 25
Q1 25
Q4 24
Q3 24
$1.1B
Q2 24
Stockholders' Equity
AR
AR
CBT
CBT
Q1 26
$7.6B
Q4 25
$7.6B
$1.6B
Q3 25
$7.3B
$1.6B
Q2 25
$7.3B
$1.5B
Q1 25
$7.2B
$1.4B
Q4 24
$7.0B
$1.4B
Q3 24
$7.0B
$1.4B
Q2 24
$7.0B
$1.3B
Total Assets
AR
AR
CBT
CBT
Q1 26
$13.2B
Q4 25
$13.2B
$3.8B
Q3 25
$12.9B
$3.8B
Q2 25
$12.8B
$3.8B
Q1 25
$13.0B
$3.8B
Q4 24
$13.0B
$3.6B
Q3 24
$13.2B
$3.7B
Q2 24
$13.4B
$3.6B
Debt / Equity
AR
AR
CBT
CBT
Q1 26
0.19×
Q4 25
Q3 25
0.70×
Q2 25
Q1 25
Q4 24
Q3 24
0.75×
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AR
AR
CBT
CBT
Operating Cash FlowLast quarter
$457.7M
$126.0M
Free Cash FlowOCF − Capex
$57.0M
FCF MarginFCF / Revenue
6.7%
Capex IntensityCapex / Revenue
8.1%
Cash ConversionOCF / Net Profit
1.73×
TTM Free Cash FlowTrailing 4 quarters
$401.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AR
AR
CBT
CBT
Q1 26
$457.7M
Q4 25
$370.7M
$126.0M
Q3 25
$310.1M
$219.0M
Q2 25
$492.4M
$249.0M
Q1 25
$457.7M
$73.0M
Q4 24
$278.0M
$124.0M
Q3 24
$166.2M
$204.0M
Q2 24
$143.5M
$207.0M
Free Cash Flow
AR
AR
CBT
CBT
Q1 26
Q4 25
$57.0M
Q3 25
$155.0M
Q2 25
$188.0M
Q1 25
$1.0M
Q4 24
$47.0M
Q3 24
$112.0M
Q2 24
$155.0M
FCF Margin
AR
AR
CBT
CBT
Q1 26
Q4 25
6.7%
Q3 25
17.2%
Q2 25
20.4%
Q1 25
0.1%
Q4 24
4.9%
Q3 24
11.2%
Q2 24
15.3%
Capex Intensity
AR
AR
CBT
CBT
Q1 26
Q4 25
8.1%
Q3 25
7.1%
Q2 25
6.6%
Q1 25
7.7%
Q4 24
8.1%
Q3 24
9.2%
Q2 24
5.1%
Cash Conversion
AR
AR
CBT
CBT
Q1 26
Q4 25
1.83×
1.73×
Q3 25
3.62×
5.09×
Q2 25
2.96×
2.47×
Q1 25
2.09×
0.78×
Q4 24
1.75×
1.33×
Q3 24
1.49×
Q2 24
1.90×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AR
AR

Natural gas sales$780.0M58%
Natural gas liquids sales$561.4M42%
Oil sales$50.3M4%
Other revenue and income$818.0K0%

CBT
CBT

Reinforcement Materials$520.0M61%
Performance Chemicals$300.0M35%
Shipping And Handling$25.0M3%
Other Products And Services$4.0M0%

Related Comparisons